Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IFOSFAMIDE vs IMATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IFOSFAMIDE vs IMATINIB: Safety Overview

Metric IFOSFAMIDE IMATINIB
Total FAERS Reports 17,004 43,161
Deaths Reported 3,365 13,761
Death Rate 19.8% 31.9%
Hospitalizations 5,230 7,264
Average Patient Age 36.2 yrs 55.7 yrs
% Female Patients 41.7% 47.2%
FDA Approval Date Apr 4, 2007 Apr 14, 2025
Manufacturer Baxter Healthcare Corporation Dr.Reddy's Laboratories Inc
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued